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Abstract. Ca
2+ is a central player in the excitation-contraction coupling of cardiac myocytes, the process that enables the heart to contract and relax. Mishandling of Ca 2+ is a central cause of both contractile dysfunction and arrhythmias in pathophysiological conditions such as heart failure (HF ] i affinity unless it is phosphorylated). Here we discuss the interplay between Ca 2+ and Na + in myocytes from normal and failing hearts.
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Cardiac excitation-contraction coupling
Contraction of the heart is a complex process initiated by the electrical excitation of cardiac myocytes (excitation-contraction coupling, ECC). The wave of depolarization initiated in the sino-atrial node propagates through the atrium and atrio-ventricular node to the ventricle. When the wave of depolarization reaches a ventricular myocyte, voltage-dependent Na + channels open ( Fig. 1) , which results in a rapid cell depolarization (the upstroke of the action potential, AP). Na + channels inactivate rapidly (within a few milliseconds) at positive potentials, which limits the gain in intracellular Na
During depolarization, Ca
2+ enters the cell via voltage-dependent Ca 2+ channels (mainly L-type channels) generating an inward current (I Ca ) that is responsible for the plateau phase of the AP (2). L-Type Ca 2+ channels are located primarily at sarcolemmal -sarcoplasmic reticulum (SR) junctions where the SR Ca 2+ release channels (or ryanodine receptors: RyRs) exist (Fig. 1 ] i , via NCX.
Mishandling of Ca
2+ is a central cause of both contractile dysfunction and arrhythmias in pathophysiological conditions such as heart failure (HF).
NCX can operate in both Ca 2+ efflux and Ca 2+ influx (or reverse) mode, depending on the internal and external concentration of both Na + and Ca
2+
, as well as on the membrane potential. NCX exhibits a reversal potential E Na/ Ca = 3 E Na -2 E Ca , where E Na and E Ca are equilibrium potentials for Na + and Ca
. -ATPase and only 7% being extruded via NCX (Fig. 2B) . The balance of fluxes in mouse ventricle is quantitatively like rat, whereas in dog, cat, guinea pig, and human ventricle, it resembles the rabbit (2) .
How is the balance of Ca 2+ fluxes altered in HF? 
Interplay Between Ca
2+ and Na + in the Heart 317
Most heart failure models, including human HF, are characterized by a decrease in functional SR Ca 2+ -ATPase expression and / or an upregulation of NCX expression and function ( Fig. 3) , while I Ca is generally unchanged (for reviews, see refs. 2 and 7). SR Ca 2+ -ATPase is under reversible regulation by phospholamban (PLB). Dephosphorylated PLB inhibits SERCA activity by reducing its apparent Ca 2+ affinity, with no effect on the maximum pumping rate. Phosphorylation of PLB by either cAMP dependent-(PKA) or Ca 2+ -calmodulin-dependent protein kinase (CaMKII) relieves the SERCA inhibition. Relief of the inhibitory PLB effect on SERCA is a major contributor to the overall positive inotropic and lusitropic effect of sympathetic stimulation. PLB expression level is typically unaltered in HF, although the extent of phosphorylation is reduced (8, 9) . Therefore, the PLB:SERCA ratio is generally increased and the PLB that is there is more inhibitory.
Both factors lower SR Ca

2+
-ATPase function in HF. In a non-ischemic HF model in rabbits (pressure and volume overload), where SR Ca
-ATPase is only slightly depressed, SERCA and PLB expression and PLB phosphorylation were not significantly reduced (10) . However, PLB phosphorylation at Ser16 (PKA site) was decreased, whereas phosphorylation at Thr17 (CaMKII site) was increased (10) , effects that might cancel each other functionally.
The decreased SERCA activity in HF (typically between 24% -50%) coupled with an increased NCX activity (typically 50% -100%) allows NCX to compete better with the SR Ca
2+ -ATPase in extruding Ca
2+ from the cytosol during relaxation. This brings the overall Ca 2+ transported by the SR Ca
2+
-ATPase and NCX closer to equal in HF. For example, the 100% increase in NCX and 24% decrease in SERCA function in a nonischemic, arrhythmogenic rabbit heart failure model (11) Interplay Between Ca 2+ and Na + in the Heart 319 upregulation is compensatory in allowing NCX to still extrude the greater amount of Ca 2+ that enters during the AP (to maintain the steady-state).
Na
+ fluxes in myocytes from control and failing hearts
We have discussed above that [Na + ] i is elevated in heart failure. There are two possible explanations for this: 1) decreased Na + extrusion and 2) increased Na + influx in HF. Na + enters the cell through various pathways, including NCX, Na + channels and Na + / H + exchanger (NHE), whereas NKA is the main route for Na + efflux. Na + can also be extruded by NCX working in the reverse mode (Ca 2+ influx, Na + efflux). However, as discussed above, throughout the cardiac cycle there is net Na + influx via NCX. NKA transports three Na + ions out and two K + ions into the cell using the energy of one ATP molecule, and thus moves out one net charge per cycle. The Na + / K + ATPase has two major subunits: α, which contains the binding sites for ATP, Na + , K + , and cardiac glycosides, and β, which is important in the proper membrane insertion of the pump. Four α (α 1 -α 4 ) and three β (β 1 -β 3 ) subunits of NKA have been identified. Multiple NKA isoforms exist in cardiac cells from most species, and they might differ functionally because of differential specific intracellular localization, regulation, or kinetic characteristics.
Decreased NKA expression and/ or isoform shifts have been found in several, but not all HF models (for a review, see ref. 20) . Part of the disagreement may reflect differences in species, HF models, and differences in the human HF population. Most of these studies were performed in tissue homogenates and might reflect changes in non-myocytes. Indeed, Bossuyt et al. (25) found that NKA α 3 expression was increased in left ventricular tissue homogenates but reduced in isolated myocytes from rabbit failing hearts, suggesting a marked upregulation of α 3 expression in non-myocytes in the failing heart. Moreover, such measurements cannot differentiate between internalized vs. sarcolemmal NKA nor between functional and inactive pumps. Thus, it is difficult to correlate such biochemical findings to cellular function.
There ] i rise upon NKA inhibition, was twice as large as in myocytes from normal hearts. Most of this elevated Na + entry was tetrodotoxin (TTX)-sensitive, suggesting a role for Na + channels. Indeed, an increased slowly inactivating Na + current was found in ventricular myocytes from a canine ischemic model of HF (28) and more recently in dogs with pacing-induced HF (29). The latter study also reports an increased slowly inactivating Na + current in human HF. Baartscheer et al. (22) also found elevated Na + influx to explain elevated [Na + ] i in myocytes from HF rabbits (using essentially the same animal model we used). However, in their case, the enhanced Na + influx was inhibited by cariporide, suggesting an important role for NHE, which was upregulated. NHE has been suggested to play a prominent role in hypertrophy and HF and Baartscheer et al. (30) found that chronic NHE inhibition with cariporide prevents the onset of HF in rabbits with pressure and volume overload. Although cariporide at the concentrations used might also inhibit slowly inactivating Na + channels (31), this raises another potential explanation for elevated [Na + ] i in HF. The close interplay between Na + and Ca 2+ in heart (via NCX) makes it especially important to understand this point better.
NKA regulation by phospholemman in normal and failing hearts
We found reduced NKA expression in ventricular myocytes from HF rabbits (25); however, the characteristics of NKA-mediated Na + extrusion were unchanged (21). One possible explanation for an unaltered function despite fewer pumps might be that NKA is regulated differently in HF.
The FXYD protein family has emerged as tissue specific modulators of NKA. The FXYD proteins are single membrane spanning proteins containing a conserved Pro-Phe-X-Tyr-Asp motif in the extracellular N-terminus domain (32). There are seven FXYD proteins (FXYD-1 to -7), including phospholemman (FXYD-1), the NKA γ-subunit (FXYD-2), and the regulator of renal Na (FXYD-4, or CHIF) . All family members, but FXYD-6, have been shown to co-immunoprecipitate with NKA α subunits and to modulate NKA function. Among the FXYD proteins, FXYD-1, known also as phospholemman (PLM), is very highly expressed in the heart. PLM, a 72 amino acid sarcolemmal protein, is unique in the FXYD family in having multiple phosphorylation sites at its cytosolic carboxyl terminus. Indeed, PLM is a major cardiac target for α-and β-adrenergic agonist mediated phosphorylation in myocytes. Quantitatively PLM phosphorylation by PKA or PKC is comparable to that of troponin I and PLB (33, 34). PKA and PKC share a common phosphorylation site (at position Ser 68), and PKC has an additional site (at Ser 63).
Crambert et al. (35) showed that PLM associates specifically (almost stoichiometrically) and stably with rat α 1 -and α 2 -Na ] i , the greater Na + influx must be compensated for by an enhanced Na + extrusion via NKA. Indeed, many early studies indicated stimulation of the Na + -pump by β-adrenergic agonists. However, there has been controversy because some NKA pump current measurements in myocytes found stimulation, inhibition, or no change upon β-adrenergic stimulation (for a review, see ref. 37). Controversy extends also to the molecular target of PKA on the NKA. The NKA α subunit can be phosphorylated by PKA, but only in the presence of detergents, while in situ the phosphorylation site may be inaccessible to the kinase (38).
Since PLM regulates NKA and is a major phosphorylation target in cardiac myocytes, we investigated whether PLM phosphorylation mediates the β-adrenergic agonists effects on NKA (36). In myocytes from wild-type mice, β-adrenergic stimulation activated NKA function, mainly by reducing the K m(Na) , both in nondialyzed myocytes (using the [Na ] i decline measurements). β-Adrenergic agonists had no effect on NKA function in myocytes from PLM-KO mice. Furthermore, β-adrenergic stimulation of wild type myocytes made the [Na + ] idependence of NKA similar to that found in the PLM-KO mice. These data suggest that PLM affects NKA function in a manner similar to the way PLB affects SERCA, a P-type pump closely related to NKA (i.e., inhibition, relieved by phosphorylation, see Fig. 5A ).
Interestingly, the association between PLM and α-subunit of NKA, as determined by co-immunoprecipitation experiments, appears to be unaffected by PKA phosphorylation (25, 39). Thus phosphorylation may change the PLM-NKA interaction but does not necessarily result in a complete dissociation (Fig. 5A ). In the analogous PLB-SERCA system, it was long thought that PLB phosphorylation caused it to dissociate from SERCA, but more recent results show that PLB remains bound to SERCA even after phosphorylation and abolition of SERCA inhibition (40).
Is NKA-PLM interaction changed in HF? In myocytes from our rabbit HF model, PLM expression is reduced by 42% (25). This reduction is more extensive than that for NKA expression, thus the PLM:NKA ratio is reduced in HF. Furthermore, a higher percentage of PLM is phosphorylated in HF (25). Both findings were also present in human HF (25). The combination of a reduced amount and more phosphorylated PLM results in less overall NKA inhibition by PLM in HF. Thus, downregulation of NKA expression in this rabbit HF model may be functionally offset by less PLM-dependent inhibition (Fig. 5B) . This may explain our finding that the characteristics of NKA function are unaltered in rabbit HF (21) . Different models of hypertrophy and HF may vary in PLM alterations. For example, short-term postmyocardial infarction rat hearts show increased PLM expression (41).
Conclusion
The numerous ion transport pathways involved in the regulation of [ 
